newsfilter
← Latest News
GlobeNewswire·

Histogen Reports Year-End 2022 Results and Provides Business Update

SAN DIEGO, March 09, 2023 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ:HSTO), a clinical-stage therapeutics company on developing potential first-in-class clinical and preclinical small molecule pan-caspase and caspase